[1]
Mienaltowski, M.J.; Birk, D.E. Structure, physiology, and biochemistry of collagens. Adv. Exp. Med. Biol., 2014, 802, 5-29.
[2]
Gordon, M.K.; Hahn, R.A. Collagens. Cell Tissue Res., 2010, 339(1), 247-257.
[3]
Shoulders, M.D.; Raines, R.T. Collagen structure and stability. Annu. Rev. Biochem., 2009, 78, 929-958.
[4]
Trelstad, R.L. Human aorta collagens: Evidence for three distinct species. Biochem. Biophys. Res. Commun., 1974, 57(3), 717-725.
[5]
Pappas, A.M.; Hyatt, G.W. The evaluation of collagen film applied to skin defects in mice. Surg. Forum, 1960, 10, 844-846.
[6]
McBride, C.M.; Healey, J.E., Jr; Butler, J.J.; White, E.C. Use collagen cloth for repair of tissue defects. Surg. Forum, 1964, 15, 70-71.
[7]
Abbenhaus, J.I.; Donald, P. The use of collagen grafts for replacement of major skin loss. Laryngoscope, 1971, 81(10), 1650-1651.
[8]
Wanke, M.; Collins, R.L.; Hartmann, R.; Linder, M.M.; Sebening, H. [Structure dependent wound healing with temporary skin substitute of collagen foam film] Frankf. Z. Pathol., 1967, 77(2), 125-134.
[9]
Friderich, H.G.; Vakilzadeh, F.; Goebel, M. Study of wound healing with animal collagen films. Z. Haut. U. Geschl. Kr., 1968, 5, 325-334.
[10]
Morgenstern, L. Experimental partial splenectomy: application of cyanoacrylate monomer tissue adhesive for hemostasis. Am. Surg., 1965, 31(11), 709-712.
[11]
Peacock, E.E., Jr; Seigler, H.F.; Biggers, P.W. Use of tanned col-lagen sponges in the treatment of liver injuries. Ann. Surg., 1965, 161, 238-247.
[12]
Preobrazhensky, N.; Goldman, I.I.; Aboyants, R.K.; Ruden-ko, T.G. Application of collagen in reconstruction of auris media. News Otolaryngol., 1973, 6, 57-62.
[13]
Dronov, A.F.; Rudenko, T.G.; Arutunova, V.A. Collagen-minomycin complex. Antibiotics (Basel), 1977, 3, 283-286.
[14]
Rudenko, T.G.; Dronov, A.F.; Geraskin, V.I.; Shtihno, O.F. Experimental application of collagen-minomycin sponge Clin. Aspects Surg. Anat. Exp. Surgery, 1979. 137-141
[15]
Segalova, N.E.; Dubinskaya, A.M.; Istranov, L.P.; Aboyants, R.K.; Nikitina, L.A.; Rudenko, T.G. Preparation and properties of composites of collagen with terrilitin. Pharm. Chem. J., 1988, 22(6), 491-495.
[16]
Istranov, L.P.; Aboyants, R.K.; Belozerskaya, G.G.; Istrano-va, E.V.; Makarov, V.A. Local hemostatic collagen materials. Pharmacy (Basel), 2007, 7, 29-32.
[17]
Vaza, A.U.; Shekhter, A.B.; Istranov, L.P.; Kanakov, I.V. Experimental development of method for stimulated healing of bone-cartilage defects. . Healthcare and medical technologies, 2008, 1 8-12
[18]
Ermolova, A.S.; Smirnova, S.V.; Hvatov, V.B.; Istranov, L.P.; Mironov, L.L.; Kolokolchikova, E.G.; Sichevsky, M.V.; Bocharova, V.S. Biological dressing for III degree burn wounds. Surgery, 2008, 10, 4-9.
[19]
Istranova, E.V.; Aboyants, R.K.; Istranov, L.P. Antimicrobal activity of collagen sponges. Pharmacy (Basel), 2011, 1, 34-37.
[20]
Istranova, E.V.; Istranov, L.P.; Aboyants, R.K.; Chertova, E.N. Ichtiol – new collagen substance. PharmacyI., 2004, 5, 34-37.
[21]
Aboyants, R.K.; Istranov, L.P.; Shekhter, A.B. Gapcol –
new osteoplastic material, 1997. 5
[22]
Levchik, E.U.; Aboyants, R.K.; Istranov, L.P.; Rudenko, T.G. External protection of the intestine anastomoses by col-lagen explants. Immunol. Lett., 1997, 56(2), 490.
[23]
Shekhter, A.B.; Rudenko, T.G.; Istranov, L.P.; Guller, A.E.; Borodulin, R.R.; Vanin, A.F. Dinitrosyl iron complexes with glutathione incorporated into a collagen matrix as a base for the design of drugs accelerating skin wound healing. Eur. J. Pharm. Sci., 2015, 78, 8-18.
[24]
Shekhter, A.B.; Guller, A.E.; Istranov, L.P.; Istranova, E.V.; Butnaru, D.V.; Vinarov, A.Z.; Zakharkina, O.L.; Kurkov, A.V.; Kantimerov, D.F.; Antonov, E.N.; Marisov, L.V.; Glybochko, P.V. [Morphology of collagen matrices for tissue engineering (biocompatibility, biodegradation, tissue response)]. Arkh. Patol., 2015, 77(6), 29-38.
[25]
Shekhter, A.B. Connective tissue as an integral system: role of cell-cell and cell-matrix interactions. Connect. Tissue Res., 1986, 15(1-2), 23-31.
[26]
Lucey, P.; Goldberg, D.J. Complications of collagen fillers. Facial Plast. Surg., 2014, 30(6), 615-622.
[27]
Parenteau-Bareil, R.; Gauvin, R.; Berthod, F. Collagen-based biomaterials for tissue engineering applications. Materials (Basel), 2010, 3(3), 1863-1887.
[28]
Motta, G.; Ratto, G.B.; De Barbieri, A.; Corte, G.; Zardi, L.; Sacco, A.; Castagnola, M. Can heterologous collagen enhance the granulation tissue growth? An experimental study. Ital. J. Surg. Sci., 1983, 13(2), 101-108.
[29]
Singh, O.; Gupta, S.S.; Soni, M.; Moses, S.; Shukla, S.; Mathur, R.K. Collagen dressing versus conventional dressings in burn and chronic wounds: a retrospective study. J. Cutan. Aesthet. Surg., 2011, 4(1), 12-16.
[30]
Veves, A.; Sheehan, P.; Pham, H.T.A. A randomized, controlled trial of Promogran (a collagen/oxidized regenerated cellulose dressing) vs standard treatment in the management of diabetic foot ulcers. Arch. Surg., 2002, 137(7), 822-827.
[31]
Lou, R.B.; Hickerson, W.L. The use of skin substitutes in hand burns. Hand Clin., 2009, 25(4), 497-509.
[32]
Landsman, A.; Taft, D.; Riemer, K. The role of collagen bioscaffolds, foamed collagen, and living skin equivalents in wound healing. Clin. Podiatr. Med. Surg., 2009, 26(4), 525-533.
[33]
Landsman, A.S.; Cook, J.; Cook, E.; Landsman, A.R.; Garrett, P.; Yoon, J.; Kirkwood, A.; Desman, E. A retrospective clinical study of 188 consecutive patients to examine the effectiveness of a biologically active cryopreserved human skin allograft (Theraskin®) on the treatment of diabetic foot ulcers and venous leg ulcers. Foot Ankle Spec., 2011, 4(1), 29-41.
[34]
Ermolov, A.S.; Smirnov, S.V.; Khvatov, V.B.; Istranov, L.P.; Koniushko, O.I.; Kolokolchikova, E.G.; Sychevsky, M.V.; Bocharova, V.S. The use of bioactive wound dressing, stimulating epithelial regeneration of IIIa-degree burn wounds. Bull. Exp. Biol. Med., 2008, 146(1), 153-157.
[35]
Corcos, J.; Collet, J.P.; Shapiro, S.; Herschorn, S.; Radomski, S.B.; Schick, E.; Gajewski, J.B.; Benedetti, A.; MacRamallah, E.; Hyams, B. Multicenter randomized clinical trial comparing surgery and collagen injections for treatment of female stress urinary incontinence. Urology, 2005, 65(5), 898-904.
[36]
Davis, N.F.; Kheradmand, F.; Creagh, T. Injectable biomaterials for the treatment of stress urinary incontinence: Their potential and pitfalls as urethral bulking agents. Int. Urogynecol. J. Pelvic Floor Dysfunct., 2013, 24(6), 913-919.
[37]
Läckgren, G.; Wåhlin, N.; Stenberg, A. Endoscopic treatment of children with vesico-ureteric reflux. Acta Paediatr. Suppl., 1999, 88(431), 62-71.
[38]
Maeda, Y.; Laurberg, S.; Norton, C.S. Perianal injectable bulking agents as treatment for faecal incontinence. Cochrane Database Syst. Rev., 2009, 15(3), CD007956.
[39]
King, J.M.; Simpson, C.B. Modern injection augmentation for glottic insufficiency. Curr. Opin. Otolaryngol. Head Neck Surg., 2007, 15(3), 153-158.
[40]
Kościński, T.; Szubert, S.; Sajdak, S. Advantages of implantation of acellular porcine-derived mesh in the treatment of human rectocele - Case report. Ann. Agric. Environ. Med., 2016, 23(4), 692-695.
[41]
Slater, N.J.; van der Kolk, M.; Hendriks, T.; van Goor, H.; Bleichrodt, R.P. Biologic grafts for ventral hernia repair: A systematic review. Am. J. Surg., 2013, 205(2), 220-230.
[42]
Kissane, N.A.; Itani, K.M.F. A decade of ventral incisional hernia repairs with biologic acellular dermal matrix. Plast. Reconstr. Surg., 2012, 130(5)(Suppl. 2), 194S-202S.
[43]
Ibrahim, A.M.S.; Ayeni, O.A.; Hughes, K.B.; Lee, B.T.; Slavin, S.A.; Lin, S.J. Acellular dermal matrices in breast surgery: A comprehensive review. Ann. Plast. Surg., 2013, 70(6), 732-738.
[44]
Atala, A. Regenerative medicine strategies. J. Pediatr. Surg., 2012, 47(1), 17-28.
[45]
Akbal, C.; Lee, S.D.; Packer, S.C.; Davis, M.M.; Rink, R.C.; Kaefer, M. Bladder augmentation with acellular dermal biomatrix in a diseased animal model. J. Urol., 2006, 176(4 Pt 2)(Suppl.), 1706-1711.
[46]
Lin, J.; Hao, J.R.; Jin, J.; Deng, S.M.; Hu, J.; Na, Y.Q. [Homologous dermal acellular matrix graft for urethral reconstruction in man (report of 16 cases)]. Zhonghua Yi Xue Za Zhi, 2005, 85(15), 1057-1059.
[47]
Atala, A.; Bauer, S.B.; Soker, S.; Yoo, J.J.; Retik, A.B. Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet, 2006, 367(9518), 1241-1246.
[48]
Raya-Rivera, A.M.; Esquiliano, D.; Fierro-Pastrana, R.; López-Bayghen, E.; Valencia, P.; Ordorica-Flores, R.; Soker, S.; Yoo, J.J.; Atala, A. Tissue-engineered autologous vaginal organs in patients: A pilot cohort study. Lancet, 2014, 384(9940), 329-336.
[49]
Hamilton, N.J.; Kanani, M.; Roebuck, D.J.; Hewitt, R.J.; Cetto, R.; Culme-Seymour, E.J.; Toll, E.; Bates, A.J.; Comerford, A.P.; McLaren, C.A.; Butler, C.R.; Crowley, C.; McIntyre, D.; Sebire, N.J.; Janes, S.M.; O’Callaghan, C.; Mason, C.; De Coppi, P.; Lowdell, M.W.; Elliott, M.J.; Birchall, M.A. Tissue-engineered tracheal replacement in a child: A 4-year follow-up study. Am. J. Transplant., 2015, 15(10), 2750-2757.
[50]
Erdogan, D.; van Gulik, T.M. Evolution of fibrinogen-coated collagen patch for use as a topical hemostatic agent. J. Biomed. Mater. Res. B Appl. Biomater., 2008, 85(1), 272-278.
[51]
Fleischer, D. Endoscopic therapy of upper gastrointestinal bleeding in humans. Gastroenterology, 1986, 90(1), 217-234.
[52]
Chang, W.K.; Srinivasa, S.; MacCormick, A.D.; Hill, A.G. Gentamicin-collagen implants to reduce surgical site infection. Ann. Surg., 2013, 258(1), 59-65.
[53]
Creanor, S.; Barton, A.; Marchbank, A. Effectiveness of a gentamicin impregnated collagen sponge on reducing sternal wound infections following cardiac surgery: a meta-analysis of randomised controlled trials. Ann. R. Coll. Surg. Engl., 2012, 94(4), 227-231.
[54]
Hussain, S.T. Local application of gentamicin-containing collagen implant in the prophylaxis and treatment of surgical site infection following vascular surgery. Int. J. Surg., 2012, 10(Suppl. 1), S5-S9.
[55]
de Bruin, A.F.J.; Gosselink, M.P.; van der Harst, E. Local application of gentamicin-containing collagen implant in the prophylaxis of surgical site infection following gastrointestinal surgery. Int. J. Surg., 2012, 10(Suppl. 1), S21-S27.
[56]
Knaepler, H. Local application of gentamicin-containing collagen implant in the prophylaxis and treatment of surgical site infection in orthopaedic surgery. Int. J. Surg., 2012, 10(Suppl. 1), S15-S20.
[57]
Grigoryants, V.; Jane, J.A., Jr; Lin, K.Y. Salvage of a complicated myelomeningocele using collagen (Duragen) and dermal (Alloderm) matrix substitutes. Case report and review of the literature. Pediatr. Neurosurg., 2007, 43(6), 512-515.
[58]
Deal, D.N.; Griffin, J.W.; Hogan, M.V. Nerve conduits for nerve repair or reconstruction. J. Am. Acad. Orthop. Surg., 2012, 20(2), 63-68.
[59]
Khaing, Z.Z.; Schmidt, C.E. Advances in natural biomaterials for nerve tissue repair. Neurosci. Lett., 2012, 519(2), 103-114.
[60]
Pabari, A.; Yang, S.Y.; Mosahebi, A.; Seifalian, A.M. Recent advances in artificial nerve conduit design: Strategies for the delivery of luminal fillers. J. Control. Release, 2011, 156(1), 2-10.
[61]
Han, S.; Wang, B.; Jin, W.; Xiao, Z.; Li, X.; Ding, W.; Kapur, M.; Chen, B.; Yuan, B.; Zhu, T.; Wang, H.; Wang, J.; Dong, Q.; Liang, W.; Dai, J. The linear-ordered collagen scaffold-BDNF complex significantly promotes functional recovery after completely transected spinal cord injury in canine. Biomaterials, 2015, 41, 89-96.
[62]
Fagerholm, P.; Lagali, N.S.; Ong, J.A.; Merrett, K.; Jackson, W.B.; Polarek, J.W.; Suuronen, E.J.; Liu, Y.; Brunette, I.; Griffith, M. Stable corneal regeneration four years after implantation of a cell-free recombinant human collagen scaffold. Biomaterials, 2014, 35(8), 2420-2427.
[63]
Sultana, Y.; Jain, R.; Aqil, M.; Ali, A. Review of ocular drug delivery. Curr. Drug Deliv., 2006, 3(2), 207-217.
[64]
Cillino, S.; Di Pace, F.; Cillino, G.; Casuccio, A. Biodegradable collagen matrix implant vs mitomycin-C as an adjuvant in trabeculectomy: A 24-month, randomized clinical trial. Eye (Lond.), 2011, 25(12), 1598-1606.
[65]
Hayek, B.; Hatef, E.; Nguyen, M.; Ho, V.; Hsu, A.; Esmaeli, B. Acellular dermal graft (AlloDerm) for upper eyelid reconstruction after cancer removal. Ophthal. Plast. Reconstr. Surg., 2009, 25(6), 426-429.
[66]
Peter, N.M.; Kumar, B. Permacol in eyelid reconstruction -- a novel use. Orbit, 2013, 32(1), 57-59.
[67]
Haynes, D.S.; Vos, J.D.; Labadie, R.F. Acellular allograft dermal matrix for tympanoplasty. Curr. Opin. Otolaryngol. Head Neck Surg., 2005, 13(5), 283-286.
[68]
Gryskiewicz, J.M. Waste not, want not: The use of AlloDerm in secondary rhinoplasty. Plast. Reconstr. Surg., 2005, 116(7), 1999-2004.
[69]
Gillogly, S.D.; Wheeler, K.S. Autologous chondrocyte implantation with collagen membrane. Sports Med. Arthrosc. Rev., 2015, 23(3), 118-124.
[70]
Grassi, A.; Zaffagnini, S.; Marcheggiani Muccioli, G.M.; Benzi, A.; Marcacci, M. Clinical outcomes and complications of a collagen meniscus implant: A systematic review. Int. Orthop., 2014, 38(9), 1945-1953.
[71]
Zaffagnini, S.; Grassi, A.; Marcheggiani Muccioli, G.M.; Bonanzinga, T.; Nitri, M.; Raggi, F.; Ravazzolo, G.; Marcacci, M. MRI evaluation of a collagen meniscus implant: A systematic review. Knee Surg. Sports Traumatol. Arthrosc., 2015, 23(11), 3228-3237.
[72]
Ferreira, A.M.; Gentile, P.; Chiono, V.; Ciardelli, G. Collagen for bone tissue regeneration. Acta Biomater., 2012, 8(9), 3191-3200.
[73]
Huang, Z.; Feng, Q.; Yu, B.; Li, S. Biomimetic properties of an injectable chitosan/nano-hydroxyapatite/ collagen composite. Mater. Sci. Eng. C, 2011, 31(3), 683-687.
[74]
Sotome, S.; Uemura, T.; Kikuchi, M.; Chen, J.; Itoh, S.; Tanaka, J.; Tateishi, T.; Shinomiya, K. Synthesis and in vivo evaluation of a novel hydroxyapatite/collagen–alginate as a bone filler and a drug delivery carrier of bone morphogenetic protein. Mater. Sci. Eng. C, 2004, 24(3), 341-347.
[75]
Van Vijven, J.P.J.; Luijsterburg, P.A.J.; Verhagen, A.P.; van Osch, G.J.V.M.; Kloppenburg, M.; Bierma-Zeinstra, S.M.A. Symptomatic and chondroprotective treatment with collagen derivatives in osteoarthritis: A systematic review. Osteoarthritis Cartilage, 2012, 20(8), 809-821.
[76]
Park, K.S.; Park, M.J.; Cho, M.L.; Kwok, S.K.; Ju, J.H.; Ko, H.J.; Park, S.H.; Kim, H.Y.; Type, I.I. Type II collagen oral tolerance; mechanism and role in collagen-induced arthritis and rheumatoid arthritis. Mod. Rheumatol., 2009, 19(6), 581-589.
[77]
Thoma, D.S.; Buranawat, B.; Hämmerle, C.H.F.; Held, U.; Jung, R.E. Efficacy of soft tissue augmentation around dental implants and in partially edentulous areas: a systematic review. J. Clin. Periodontol., 2014, 41(Suppl. 15), S77-S91.
[78]
Patino, M.G.; Neiders, M.E.; Andreana, S.; Noble, B.; Cohen, R.E. Collagen as an implantable material in medicine and dentistry. J. Oral Implantol., 2002, 28(5), 220-225.
[79]
Huang, A.H.; Niklason, L.E. Engineering of arteries in vitro. Cell. Mol. Life Sci., 2014, 71(11), 2103-2118.
[80]
Keuren, J.F.W.; Wielders, S.J.H.; Driessen, A.; Verhoeven, M.; Hendriks, M.; Lindhout, T. Covalently-bound heparin makes collagen thromboresistant. Arterioscler. Thromb. Vasc. Biol., 2004, 24(3), 613-617.
[81]
Sanz-Garcia, A.; Oliver-de-la-Cruz, J.; Mirabet, V.; Gandía, C.; Villagrasa, A.; Sodupe, E.; Escobedo-Lucea, C. Heart valve tissue engineering: How far is the bedside from the bench? Expert Rev. Mol. Med., 2015, 17, e16.
[82]
Hilkin, A.M.; Shekhter, A.B.; Istranov, L.P.; Lemenev, V.L. Collagen and its application in medicine., 1976.
[83]
Sichenikov, I.A.; Aboyants, R.K.; Dronov, A.F.; Istranov, L.P.; Nikolaev, A.V.; Shekhter, A.B. Collagenoplasty in medicine., 1978.
[84]
Serov, V.V.; Shekhter, A.B. Connective tissue (functional
morphology and general pathology); Medicina , 1981.
Download PDF Flyer